Protagonist Therapeutics (NASDAQ:PTGX – Free Report) had its target price raised by Barclays from $72.00 to $88.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. PTGX has been the topic of a number of other reports. JMP Securities raised their price target on Protagonist Therapeutics [...]
Protagonist Therapeutics (NASDAQ:PTGX) Price Target Raised to $88.00
